Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...
Basel, July 2, 2026 – Novartis today announced that the European Commission (EC) has approved Itvisma ® (onasemnogene ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Transforming the treatment and healthcare system landscape using early interventions, pioneering treatments, and innovative partnerships to avoid preventable mortality from cardiovascular disease (CVD ...
Board member since March 2023 Nationality: British/American | Year of birth: 1964 A scientist by training, John D. Young has over 35 years of experience in the healthcare industry and brings a wealth ...
Join our network of bright and curious minds What makes building a career here so rewarding? It’s being part of a community of smart, dedicated people. Professionals you can admire, learn from, and ...
Novartis uses the open-source Drupal content management framework for many key websites, including our flagship global site Novartis.com, main country sites, portals for healthcare professionals, and ...
Die lokale Geschäftseinheit ist für die Vermarktung von rund 75 verschreibungspflichtigen Medikamenten in der Schweiz verantwortlich. Zu den wichtigsten Therapiegebieten gehören Onkologie, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results